GlobeNewswire

New date for the Annual General Meeting and update of financial calendar

Share

The Board of Directors of Formpipe Software AB (publ) has, as a result of the uncertainty caused by the spread of coronavirus Covid-19, taken the decision to postpone the annual general meeting to Tuesday, June 30, 2020 at 10:00.

Formpipe has a business model with a high proportion of recurring revenues and strong cash flow, which forms the basis for the Board's proposal for dividend for 2019. Due to the global development, it is currently difficult to assess the economic consequences. By postponing the Annual General Meeting, the Board will be given the opportunity to continuously analyze and assess the situation, and based on this, evaluate the proposal for a dividend for 2019.

As a consequence of postponing the Annual General Meeting, Formpipe will also postpone the publication of the interim report for January-June until Wednesday, August 19, 2020.

Updated calendar for financial information

April 28, 2020 - Interim report January-March

Week 18 - Publication of the Annual Report

June 30, 2020 - Annual General Meeting

August 19, 2020 - Interim report January-June

October 27, 2020 - Interim report January-September


Formpipe's annual report will be available on the company's website, www.formpipe.se, and at the head office, Sveavägen 168 in Stockholm, week 18.

For additional information, contact:
Christian Sundin, President and CEO of Formpipe, +46 705 67 73 85

_______________________________________________

This is a translation of the original Swedish version. In the event of any discrepancies between the two versions, the original Swedish version shall take precedence.

This information is of the type that Formpipe is obliged to make public pursuant to the EU Market Abuse Regulation, the Swedish Securities Markets Act and the Swedish Financial Instruments Trading Act. The information was submitted for publication through the agency of the contact person set out above, on March 25, 2020, at 15.00 CET.

Formpipe develops ECM products and solutions for structuring information and supplies them to major companies, authorities and organisations. ECM products help organisations to capture, manage and distribute information, and to place it in context. The company’s software helps improve efficiency, cut costs and reduce risk exposure. Formpipe was founded in 2004 and has offices in Sweden, Denmark, United Kingdom, The Netherlands, Germany and USA. The Formpipe share is listed on NASDAQ Stockholm.

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer2.6.2020 07:00:00 CESTPress release

Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or metastatic hepatocellular carcinoma Tecentriq combination improved overall survival and progression-free survival compared to the previous standard of careApplication approved under FDA’s Project Orbis initiative and Real-Time Oncology Review pilot programme Basel, 2 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy. “We’re excited that today’s approval of Tecentriq in combination with Avastin for unresectable or metastatic hepatocellular carcinoma brings a cancer immunotherapy option to people with this aggressive form of liver cancer,” said Levi Garraway, M.D., Ph.D., Chief Medi

EXEL INDUSTRIES :2019-2020 First-Half Results The initial benefits of our reorganization blacked out by the impact of the health crisis and depreciation of goodwill 1st semester 20191st semester 20202.6.2020 07:00:00 CESTPress release

PRESS RELEASE Paris, June 2, 2020 2019-2020 First-Half Results The initial benefits of our reorganization blacked out by the impact of the health crisis and depreciation of goodwill 1st semester 20191st semester 2020in M€Oct 18 - Mar 19Oct 19 - Mar 20Revenue348.9314.3Current Operating Income5.0-1.1%1.4%-0.3%Non-recurring items-4.2-28.9Financial expenses-1.9-1.8(Losses)/gains on foreign exchange2.9-4.4Profit before tax1.7-36.2Tax expense-0.7-0.4Share of profit of associates0.20.2Net income 1.2-36.4 ·Analysis of 2019-2020 first-half results The decline in current operating income over the first-half of 2019-2020 was due primarily to the drop in revenue from Agricultural and Industrial Spraying due to the global health crisis. The reorganization initiated in 2019 produced visible results for the Sugar Beet Harvesting business. With respect to Agricultural Spraying, we expect an improvement by the end of the financial year. The very uncertain macro-economic context, notably as a result of

Mitsubishi Corporation and NTT complete acquisition of 30% stake in HERE Technologies2.6.2020 07:00:00 CESTPress release

June 2, 2020 Amsterdam and Tokyo – HERE Technologies today announced that Mitsubishi Corporation (MC) and Nippon Telegraph and Telephone Corporation (NTT) of Japan have completed their joint acquisition of a 30% ownership stake in the company, after receiving regulatory approvals. HERE welcomes MC and NTT as strategic investors. The two companies have co-invested in HERE via their recently established, jointly owned holding company COCO Tech Holding B.V. in the Netherlands. As a result, HERE now has nine direct and indirect shareholders: Audi, Bosch, BMW Group, Continental, Intel Capital, MC, Mercedes-Benz, NTT and Pioneer.​ Following the transaction, HERE has added two new members to its Supervisory Board: Mr. Yutaka Kyoya, Executive Vice President, Group CEO, Consumer Industry Group, Mitsubishi Corporation; and Mr. Hiroki Kuriyama, Member of the Board, Executive Vice President, Head of Strategic Business Development, NTT. HERE’s broadened shareholder structure supports the company’s

Prosafe SE: Update on financial situation and process with lenders2.6.2020 07:00:00 CESTPress release

Prosafe refers to the information on its financial status and process with lenders that has been provided over time and lastly in the Q1 2020 report published on 26 May 2020. The company has gained support to an extension to the previously reported forbearance arrangement with a majority of its lenders across its USD 1,300 million and USD 288 million facilities from end May 2020 till end June 2020. As part of this, the company will continue to defer making payments of scheduled instalments and interests under both facilities. Similarly, payment of the final instalment owed and due under the seller credit to Cosco for the Safe Notos remains as initially reported on 13 February subject to ongoing discussions with Cosco and the lenders. The company's discussions with its lenders remain constructive. The forbearance arrangement shows support for the company and creates stability to work with lenders to agree a long term financial solution, while lenders reserve their rights. Pending this,

EVS Broadcast Equipment reports update of share buyback program2.6.2020 06:45:00 CESTPress release

Publication on June 2, 2020, before market opening Regulated information – reporting share buyback EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS reports update of share buyback program EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on May 6, 2020, took place between May 25, 2020 and May 29, 2020. DateNumber of shares acquiredAverage price (EUR)Total (EUR)25/05/20202,500 13.7820 34,45526/05/20202,500 13.9834 34,95927/05/20202,500 14.2910 35,72828/05/20202,500 14.8076 37,01929/05/20202,500 14.4971 36,243Total12,50014.2722 178,403 As of May 29, 2020, and since the start of the buyback program, EVS has bought 27,267 shares at an average price of EUR 14,0123, representing in total EUR 382,072. After aforementioned transactions the total number of own shares amounts now to 618,319 shares as of May 29, 2020 (including 607,332 shares already held by the

Nexstim Abp: Preliminärt utfall av den lyckade företrädesemissionen1.6.2020 19:30:00 CESTPressemelding

Företagsmeddelande, insiderinformation, Helsingfors 1 juni 2020 kl. 20.30 (EEST) Nexstim Abp: Preliminärt utfall av den lyckade företrädesemissionen FÅR EJ PUBLICERAS ELLER SPRIDAS DIREKT ELLER INDIREKT I FÖRENTA STATERNA, AUSTRALIEN, SYDAFRIKA, HONGKONG, JAPAN, KANADA, SINGAPORE ELLER NÅGON ANNAN STAT DÄR SPRIDNINGEN ELLER PUBLICERINGEN STRIDER MOT LAGEN. Teckningstiden för Nexstim Abp:s (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) företrädesemission om cirka 2,3 miljoner euro (”emissionen”) avslutades 25 maj 2020 i Sverige och 27 maj 2020 i Finland. Enligt det preliminära emissionsutfallet övertecknades emissionen och cirka 273 procent av de tilldelade aktierna tecknades. Av de tilldelade 376 719 780 nya aktierna (”emissionsaktierna”) tecknades 336 033 654 emissionsaktier (cirka 89,2 procent av emissionsaktierna) med företrädesrätt och 40 686 126 emissionsaktier (cirka 10,8 procent av emissionsaktierna) tilldelas i enlighet med emissionsvillkoren. Enligt det preliminära emissio